Track record · closed signal

IMAX Corporation (IMAX) — closed signal from July 9, 2025

Target reached Published before the outcome was known, scored automatically when the window closed on October 7, 2025.

Predicted vs. what happened

IMAX price · publication thesis → realized outcomesplit-adjusted
$26.90 Published $31.20 Target $32.77 Window close $34.14 Peak
$25.40 – $25.80Entry zone — fair-value band
$26.90Published — price the day we called it
$31.20Target — the price the thesis aimed for
$34.14Peak — highest point inside the window, not a realized return
$32.77Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 61 days.

Peak price
$34.14
peak on October 3, 2025 — not a realized return
Peak gain
+26.9%
peak, from the publication price
Window close
$32.77
end-of-window price, context only
Days to target
61
Window
July 9, 2025 – October 7, 2025

The thesis — published July 9, 2025

Predicted growth
+16%
over the measurement window
Target price
$31.20
the price the thesis aimed for
Entry zone
$25.40 – $25.80
the fair-value band we waited for
Price at publication
$26.90
published July 9, 2025
Confidence
66%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

IMAX turns 40% of its sales into extra cash, but the share price has slid 15% and is valued like a regular theater chain. Short-term trading signals hint buyers may return. Benchmark kept its $30 target on Jul 9 after IMAX screens captured a record share, helped by "F1 The Movie" bringing in $28 million. With more summer hits coming, the stock could climb back above $30.

Primary drivers

  • Short-term signal shows the stock may have fallen too far and could bounce soon.
  • On July 9, research firm Benchmark repeated its $30 price goal.
  • The company turns a big chunk of sales into cash because it owns few hard assets.
  • Summer hit movies are sending more viewers to IMAX screens than ever.

How it played out

IMAX: target reached in 61 days

Lyra published IMAX on July 9, 2025 at $26.90. The thesis expected 16% growth and pointed to a short-term bounce setup after a 15% slide, Benchmark's $30 price goal on July 9, cash generation from a light asset base, and summer films sending more viewers to IMAX screens.

Inside the window, the stock reached the $31.20 goal in 61 days. It later peaked at $34.14 on October 3, with a 26.9% peak gain. It ended the window at $32.77. The thesis played out.

What happened during the window

On September 18, 2025, Axios reported that Netflix's "Frankenstein" would have a limited IMAX theatrical run. The article tied the item to comments from IMAX CEO Richard Gelfond at Axios Media Trends Live.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All IMAX signals